Gastroenterology

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy



p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy

Source link

Related posts

Fecal transplantation, vancomycin superior for recurrent C. diff

Newsemia

Greater recurrence of CRC in late-onset vs early onset IBD

Newsemia

Rivaroxaban reduces VTE among ambulatory patients with pancreatic cancer

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World